Verition Fund Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-60,037
| Closed | -$430K | – | 2674 |
|
|
2024
Q2 | $430K | Buy |
+60,037
| New | +$430K | ﹤0.01% | 1535 |
|
|
2023
Q3 | – | Sell |
-153,946
| Closed | -$1.91M | – | 2160 |
|
|
2023
Q2 | $1.91M | Buy |
153,946
+139,955
| +1,000% | +$1.74M | 0.03% | 605 |
|
|
2023
Q1 | $196K | Sell |
13,991
-8,892
| -39% | -$125K | ﹤0.01% | 1611 |
|
|
2022
Q4 | $327K | Buy |
+22,883
| New | +$327K | 0.01% | 1166 |
|
|
2022
Q3 | – | Sell |
-32,244
| Closed | -$916K | – | 2545 |
|
|
2022
Q2 | $916K | Buy |
32,244
+6,020
| +23% | +$171K | 0.02% | 1047 |
|
|
2022
Q1 | $925K | Buy |
+26,224
| New | +$925K | 0.01% | 1008 |
|
|
2021
Q3 | – | Sell |
-5,850
| Closed | -$244K | – | 1913 |
|
|
2021
Q2 | $244K | Buy |
+5,850
| New | +$244K | ﹤0.01% | 1325 |
|